Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Ely

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|July 19, 2006
Using aspirates for multiple myeloma research probably excludes important dataScott Ely
Translational Research : the Journal of Laboratory and Clinical Medicine|November 26, 2009
Personalized medicine: individualized care of cancer patientsScott Ely
Blood|October 18, 2002
Observing autoimmune patients may not be appropriate for testing "normal" immunoregulatory mechanismsScott Ely
Leukemia Research|August 21, 2010
Renewed interest in myeloma tumor growth, or just one more method to assess proliferation?Scott Ely
Current Hematologic Malignancy Reports|September 17, 2014
Controversies in the assessment of minimal residual disease in multiple myeloma: clinical significance of minimal residual disease negativity using highly sensitive techniquesNoa Biran, Scott Ely, Ajai Chari
Current Hematologic Malignancy Reports|October 4, 2014
What we mean when we talk about MRD in myeloma. A review of current methods. Part 1 of a two-part seriesScott Ely, Noa Biran, Ajai Chari
Clinical Immunology (Orlando, Fla.)|June 22, 2012
Lymph node vascular-stromal growth and function as a potential target for controlling immunityFairouz Benahmed, Scott Ely, Theresa T Lu
The American Journal of Pathology|October 9, 2002
DNA polymerase mu gene expression in B-cell non-Hodgkin's lymphomas: an analysis utilizing in situ hybridizationApril Chiu, Langxing Pan, Zongdong Li, et al.
Hematological Oncology|October 18, 2006
Osteopontin dysregulation and lytic bone lesions in multiple myelomaDavide F Robbiani, Kaity Colon, Sarah Ely, et al.
Leukemia & Lymphoma|July 2, 2011
De novo B lymphoblastic leukemia/lymphoma in an adult with t(14;18)(q32;q21) and c-MYC gene rearrangement involving 10p13Shivakumar Subramaniyam, Cory R Fraser, Pulivarthi H Rao, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|July 19, 2006
Using aspirates for multiple myeloma research probably excludes important dataScott Ely
Translational Research : the Journal of Laboratory and Clinical Medicine|November 26, 2009
Personalized medicine: individualized care of cancer patientsScott Ely
Blood|October 18, 2002
Observing autoimmune patients may not be appropriate for testing "normal" immunoregulatory mechanismsScott Ely
Leukemia Research|August 21, 2010
Renewed interest in myeloma tumor growth, or just one more method to assess proliferation?Scott Ely
Current Hematologic Malignancy Reports|September 17, 2014
Controversies in the assessment of minimal residual disease in multiple myeloma: clinical significance of minimal residual disease negativity using highly sensitive techniquesNoa Biran, Scott Ely, Ajai Chari
Current Hematologic Malignancy Reports|October 4, 2014
What we mean when we talk about MRD in myeloma. A review of current methods. Part 1 of a two-part seriesScott Ely, Noa Biran, Ajai Chari
Clinical Immunology (Orlando, Fla.)|June 22, 2012
Lymph node vascular-stromal growth and function as a potential target for controlling immunityFairouz Benahmed, Scott Ely, Theresa T Lu
The American Journal of Pathology|October 9, 2002
DNA polymerase mu gene expression in B-cell non-Hodgkin's lymphomas: an analysis utilizing in situ hybridizationApril Chiu, Langxing Pan, Zongdong Li, et al.
Hematological Oncology|October 18, 2006
Osteopontin dysregulation and lytic bone lesions in multiple myelomaDavide F Robbiani, Kaity Colon, Sarah Ely, et al.
Leukemia & Lymphoma|July 2, 2011
De novo B lymphoblastic leukemia/lymphoma in an adult with t(14;18)(q32;q21) and c-MYC gene rearrangement involving 10p13Shivakumar Subramaniyam, Cory R Fraser, Pulivarthi H Rao, et al.
Pageof 5